MyAverix Finance
US · Healthcare
Spyre Therapeutics Inc (SYRE)
Biotechnology
Spyre Therapeutics Inc (SYRE) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $6.43B, P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for SYRE
Spyre Therapeutics Inc (SYRE) — FAQ
What is Spyre Therapeutics Inc's market cap?
Spyre Therapeutics Inc (SYRE) has a reported market cap of $6.43B (data as of 2026-05-24).
What is SYRE's P/E ratio?
The price-to-earnings (P/E) ratio for Spyre Therapeutics Inc (SYRE) is 25.00 (data as of 2026-05-24).
Does Spyre Therapeutics Inc pay a dividend?
Dividend yield is not available in the current snapshot for Spyre Therapeutics Inc (SYRE). Check the MyAverix Finance app for the latest dividend data.
What sector is Spyre Therapeutics Inc in?
Spyre Therapeutics Inc (SYRE) is classified in the Healthcare sector (Biotechnology industry).
What exchange is SYRE listed on?
SYRE is listed on US.
What is Spyre Therapeutics Inc's net margin?
Spyre Therapeutics Inc (SYRE) reports a net margin of 0.0% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.